Discoidin domain receptor inhibitors as anticancer agents: A systematic review on recent development of DDRs inhibitors, their resistance and structure activity relationship
- 21 October 2022
- journal article
- review article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 130, 106215
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasisNature Cell Biology, 2013
- The extracellular matrix: A dynamic niche in cancer progressionJournal of Cell Biology, 2012
- Nilotinib: A Novel, Selective Tyrosine Kinase InhibitorSeminars in Oncology, 2011
- Collagen binding specificity of the discoidin domain receptors: Binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1Matrix Biology, 2011
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Mutations in DDR2 Gene Cause SMED with Short Limbs and Abnormal CalcificationsThe American Journal of Human Genetics, 2009
- Somatic mutations affect key pathways in lung adenocarcinomaNature, 2008
- Congenital disease SNPs target lineage specific structural elements in protein kinasesProceedings of the National Academy of Sciences, 2008
- Collagen I–mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1Journal of Cell Biology, 2008
- Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinomaBritish Journal of Cancer, 2007